Infectious disease complications of GI endoscopy: Part II, exogenous infections

Gastrointestinal Endoscopy

Volumn 57, Issue 5, 2003, Pages 695-711

  Nelson, Douglas B ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; ALCOHOL; ALKYLDIAMINOETHYLGLYCINE; BENZALKONIUM CHLORIDE; BENZETHONIUM CHLORIDE; CETRIMIDE; CHEMOSTERILANT; CHLORHEXIDINE; GLUTARALDEHYDE; HEXACHLOROPHENE; HYDROGEN PEROXIDE; IODOPHOR; PERACETIC ACID; PHENOL; PHENOL DERIVATIVE; PHTHALALDEHYDE; POVIDONE IODINE; QUATERNARY AMMONIUM DERIVATIVE;

DISEASE TRANSMISSION; DISINFECTION; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; INFECTION RISK; PRACTICE GUIDELINE; PRION DISEASE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA; BACTERIAL FLORA; BACTERIAL INFECTION; DEVICE INFECTION; GASTROENTEROLOGY; GASTROINTESTINAL ENDOSCOPE; INSTRUMENT STERILIZATION; PATHOGENESIS; VIRUS INFECTION;

EID: 0038784126     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.202     Document Type: Review

References (128)

1. Food and Drug Administration. Medical device reporting (MDR). Available at: http://www.fda.gov/cdrh/mdr/. Accessed November 20, 2002.
2. Hirschowitz BI. Endoscopic examination of the stomach and duodenal cap with the fiberscope. Lancet 1961;1:1074-8.
3. Petersen BT. Gaining perspective on reprocessing of GI endoscopes. Gastrointest Endosc 1999;50:287-91.
4. Axon ATR, Phillips I, Cotton PB, Avery SA. Disinfection of gastrointestinal fibre endoscopes. Lancet 1974;I:656-8.
5. Whalen GE. Risks of hepatitis: what can be done [letter]? Gastrointest Endosc 1975;22:48-9.
6. Tolon M, Thofern E, Miederer SE. Disinfection procedures of fiberscopes in endoscopy departments. Endoscopy 1976;8:24-9.
7. Dunkerley RC, Cromer MD, Edmiston Jr CE, Dunn GD. Practical technique for adequate cleansing of endoscopes: a bacteriological study of Phisohex and Betadine. Gastrointest Endosc 1977;23:148-9.
8. Carr-Locke DL, Clayton P. Disinfection of upper gastrointestinal fibreoptic endoscopy equipment: an evaluation of a cetrimide chlorhexidine solution and glutaraldehyde. Gut 1978;19:916-22.
9. Geenen JE, Pfeifer M, Simonsen L. Cleaning and disinfection of endoscopic equipment [letter]. Gastrointest Endosc 1978;24:185-6.
10. Hedrick E. Cleaning and disinfection of flexible fiberoptic endoscopes used in gastrointestinal endoscopy. APIC J 1978;6:8-9.
11. Lindstaedt H, Krizek L, Miederer SE, Botzenhart K. Experience and problems in the disinfection of fibre endoscopes. Endoscopy 1978;10:80-5.
12. Vennes JA, Geenen JE, Papp JP, Schapiro M. Endoscopically related infections and their prevention [letter]. Gastrointest Endosc 1981;27:239-40.
13. Axon ATR, Banks J, Cockel R, Deverill CEA, Newman C. Disinfection in upper-digestive-tract endoscopy in Britain. Lancet 1981;I:1093-4.
14. Rutala WA. APIC guideline for selection and use of disinfectants. Am J Infect Control 1996;24:313-42.
15. Infection control during gastrointestinal endoscopy: guidelines for clinical application. Gastrointest Endosc 1988;34:37S-40S.
16. Weller IVD, Williams CB, Jeffries DJ, Gazzard BG, Axon ATR, Hanson PJV, et al. Cleaning and disinfection of equipment for gastrointestinal flexible endoscopy: interim recommendations of a working party of the British Society of Gastroenterology. Gut 1988;29:1134-51.
17. Sobala GM, Lincoln C, Axon AT. Does the endoscope control head need to be disinfected between examinations? Endoscopy 1989;21:19-21.
18. DiMarino Jr. AJ, Leung J, Ravich W, Wolf D, Zuckerman G, Walters V, et al. Reprocessing of flexible gastrointestinal endoscopes. Gastrointest Endosc 1996;43:540-6.
19. Society of Gastroenterology Nurses and Associates, Inc. Standards of infection control in reprocessing of flexible gastrointestinal endoscopes. Gastroenterol Nurs 2000;23:172-87.
20. Alvarado CJ, Mark R. APIC guidelines for infection prevention and control in flexible endoscopy. Am J Infect Control 2000;28:138-55.
21. American Society for Testing and Materials. Standard practice for cleaning and disinfection of flexible fiberoptic and video endoscopes used in the examination of the hollow viscera. F1518-00. West Conshohocken; 2000.
22. BSG Endoscopy Committee Working Party. Cleaning and disinfection of equipment for gastrointestinal endoscopy. Report of a working party of the British Society of Gastroenterology Endoscopy Committee. Gut 1998;42:585-93.
23. European Society of Gastrointestinal Endoscopy. Guidelines on cleaning and disinfection in GI endoscopy. Endoscopy 2000;32:77-83.
24. Leung JW. Working party report: care of endoscopes. Reprocessing of flexible endoscopes. J Gastroenterol Hepatol 2000;15:G73-7.
25. Alvarez SZ, Kothari K, Novis B, Xiao SD, Rainoldi JL, Khelifa HB, et al. Disinfection of endoscopic equipment. Gastrointest Endosc 1999;49:668-70.
26. Morris IM, Cattle DS, Smits BJ. Endoscopy and transmission of hepatitis B [letter]. Lancet 1975;II:1152.
27. Seefeld U, Bansky G, Jaeger M, Schmid M. Prevention of hepatitis B virus transmission by gastrointestinal fibrescope: successful disinfection with an aldehyde liquid. Endoscopy 1981;13:238-9.
28. Birnie GG, Quigley EM, Clements GB, Follet EAC, Watkinson G. Endoscopic transmission of hepatitis B virus. Gut 1983;24:171-4.
29. Davis AR, Pink JM, Kowalik AM, Wylie BR, McCaughan GW. Multiple endoscopies in a Sydney blood donor found positive for hepatitis B and C antibodies. Med J Aust 1996;164:571.
30. Federman DG, Kirsner RS. Leukocytoclastic vasculitis, hepatitis B, and the risk of endoscopy. Cutis 1999;63:86-7.
31. McDonald GB, Silverstein FE. Can gastrointestinal endoscopy transmit hepatitis B to patients? Gastrointest Endosc 1976;22:168-70.
32. McClelland DBL, Burrell CJ, Tonkin RW, Heading RC. Hepatitis B: absence of transmission by gastrointestinal endoscopy. Br Med J 1978;1:23-4.
33. Moncada RE, Denes AE, Berquist KR, Fields HA, Murphy BL, Maynard JE. Inadvertent exposure of endoscopy patients to viral hepatitis B. Gastrointest Endosc 1978;24:231-2.
34. Morgan AG, McAdam WAF, Walker BE. Hepatitis B and endoscopy [letter]. Br Med J 1978;1:369.
35. Chiaramonte M, Farini R, Truscia D, Zampieri L, Di Mario F, Pornaro E, et al. Risk of hepatitis B virus infection following upper gastrointestinal endoscopy: a prospective study in an endemic area. Heptogastroenterology 1983;30:189-91.
36. Koretz RL, Camacho R. Failure of endoscopic transmission of hepatitis B. Dig Dis Sci 1979;24:21-4.
37. Hoofnagle JH, Blake J, Buskell-Bales Z, Seeff LB. Lack of transmission of type B hepatitis by fiberoptic upper endoscopy. J Clin Gastroenterol 1980;2:65-9.
38. Ayoola EA. The risk of type B hepatitis infection in flexible fiberoptic endoscopy. Gastrointest Endosc 1981;27:60-1.
39. Villa E, Pasquinelli C, Rigo G, Ferrari A, Perini M, Ferretti I, et al. Gastrointestinal endoscopy and HBV infection: no evidence for a causal relationship. Gastrointest Endosc 1984;30:15-7.
40. Lok AS, Lai CL, Hui WM, Ng MM, Wu PC, Lam SK, et al. Absence of transmission of hepatitis B by fibreoptic upper gastrointestinal endoscopy. J Gastroenterol Hepatol 1987;2:175-90.
41. Ferrari AP, Geocze S, Ferraz MLG, Silva AEB, Vilela MP. Lack of evidence of upper gastrointestinal endoscopy as a risk factor for transmission of hepatitis B virus [letter]. Endoscopy 1991;23:353.
42. Petrosillo N, Puro V, Jagger J, Ippolito G. The risks of occupational exposure and infection by HIV, hepatitis B virus, and hepatitis C virus in the dialysis setting. Am J Infect Control 1995;23:278-85.
43. Tennenbaum R, Colardelle P, Chochon M, Maisonneuve P, Jean F, Andrieu J. Hépatite C après cholangiographie rétrograde [French]. Gastroenterol Clin Biol 1993;17:763-75.
44. Bronowicki JP, Venard V, Botté C, Monhoven N, Gastin I, Choné L, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997;337:237-40.
45. Le Pogam S, Gondeau A, Bacq Y. Nosocomial transmission of hepatitis C virus [letter]. Ann Intern Med 1999;131:794.
46. Taylor CL. Brooklyn bug/clinic linked to 8 cases of hepatitis C; 2200 at risk. Newsday. June 9, 2001;A05.
47. Frieden TR. Multi use vials letter (New York City Department of Health Website). Available at: http://www. nyc.gov/html/doh/pdf/chi/ltr2-2002.pdf. Accessed December 1, 2002.
48. Ramirez M. Cause of infection/report: anesthesiologist contaminated medicine vial. Newsday. July 3, 2002;A03.
49. Andrieu J, Barny S, Colardelle P, Maisonneuve P, Giraud V, Robin E, et al. Prévalence et facteurs de risque de l'infection par le virus de l'hépatite C dans une population hospitalisée en Gastroentérologie: role des biopsies per endoscopiques [French with English abstract]. Gastroenterol Clin Biol 1995;19:340-5.
50. Merle V, Goria O, Gourier-Frery C, Benguigui C, Michel P, Huet P, et al. Facteurs de risque de contamination par le virus de l'hépatite C: etude cas-témoins en population générale [French with English abstract]. Gastroenterol Clin Biol 1999;23:439-46.
51. Elghouzzi MH, Bouchardeau F, Pillonel J, Boiret E, Tirtaine C, Barlet V, et al. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang 2000;79:138-44.
52. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Gamil F, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 2001;33:248-53.
53. Mele A, Spada E, Sagliocca L, Ragni P, Tosti ME, Gallo G, et al. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J Hepatol 2001;35:284-9.
54. Trasancos CC, Kainer MA, Desmond PV, Kelly H. Investigation of potential iatrogenic transmission of hepatitis C in Victoria, Australia. Aust N Z J Public Health 2001;25:241-4.
55. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002;17:1092-7.
56. Kim YS, Ahn YO, Lee HS. Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype. J Korean Med Sci 2002;17:187-92.
57. Sackett DL. Bias in analytic research. J Chron Dis 1979;32:51-63.
58. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C infection. N Engl J Med 1996;334:1691-6.
59. Collignon P, Graham E. How well are endoscopes cleaned and disinfected between patients? Med J Aust 1989;151:269-72.
60. Van Gossum A, Loriers M, Serruys E, Cremer M. Methods of disinfecting endoscopic material: results of an international survey. Endoscopy 1989;21:247-50.
61. Orsi GB, Filocamo A, Di Stefano L, Tittobello A. Italian national survey of digestive endoscopy disinfection procedures. Endoscopy 1997;29:732-40.
62. Leung JW. Working party report: care of endoscopes. Reprocessing of flexible endoscopes. J Gastroenterol Hepatol 2000;15:G73-7.
63. Rey JF, Halfon P, Feryn JM, Khiri H, Masseyeff MF, Ouzan D. Risque de transmission du virus de l'hépatite C par l'endoscopie digestive [French]. Gastroenterol Clin Biol 1995;19:346-9.
64. Deva AK, Vickery K, Zou J, West RH, Selby W, Benn RA, et al. Detection of persistent vegetative bacteria and amplified viral nucleic acid from in-use testing of gastrointestinal endoscopes. J Hosp Infect 1998;39:149-57.
65. Chanzy B, Duc-Bin DL, Rousset B, Morand P, Morel-Baccard C, Marchetti B, et al. Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointest Endosc 1999;50:147-51.
66. Bécheur H, Harzic M, Colardelle P, Deny P, Coste T, Dubeaux B, et al. Contamination des endoscopes et des pinces à biopsies par le virus de l'hépatite C [French with English abstract]. Gastroenterol Clin Biol 2000;24:906-10.
67. Deflandre J, Cajot O, Brixko C, Crine M, Labalue J, Senterre J. Risques de contamination par le virus de l'hépatite C des endoscopes utilisés dans un service hospitalier de gastroentérologie [French with English abstract]. Rev Med Liege 2001;56:696-8.
68. Classen M, Dancygier II H, Gürtler L, Deinhardt F. Risk of transmitting HIV by endoscopes [letter]. Endoscopy 1988;20:128.
69. Hanson PJV, Gor D, Clarke JR Chadwick MV, Nicholson G, Shah N, et al. Contamination of endoscopes used in AIDS patients. Lancet 1989;II:86-8.
70. Hanson PJV, Gor D, Jeffries DJ, Collins JV. Elimination of high titre HIV from fiberoptic endoscopes. Gut 1990;31:657-9.
71. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States: 1979-1995 [letter]. JAMA 2000;284:2322-3.
72. World Health Organization. WHO infection control guidelines for transmissible spongiform encephalopathies. 1999; WHO/CDS/CSR/APH/2000.3; Geneva. Available from: URL: http://www.who.int/emc-documents/tse/whocdscsraph2003c.html.
73. Rutala WA, Weber DJ. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis 2001;32:1348-56.
74. Antloga K, Meszaros J, Malchesky PS, McDonnell GE. Prion disease and medical devices. ASAIO J 2000;46:S69-S72.
75. Dickinson AG, Taylor DM. Resistance of scrapie agent to decontamination [letter]. N Engl J Med 1978;299:1413-4.
76. Taylor DM. Resistance of the ME7 scrapie agent to peracetic acid. Vet Microbiol 1991;27:19-24.
77. Favero MS, Bond WW. Disinfection of medical and surgical materials. In: Block SS, editor. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams and Wilkins 2001:881-917.
78. Wadsworth JDF, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, et al. Tissue distribution of protease resistant prion in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-80.
79. Centers for Disease Control and Prevention. BSE and CJD information and resources [cited 2000 Dec 11]. Available from: http://www.cdc.gov/ncidod/diseases/cjd/cjd.htm.
80. Hill AF, Zeidler M, Ironside JW, Collinge J. Diagnosis of new variant Creuzfeldt-Jakob disease by tonsil biopsy [letter]. Lancet 1997;349:99-100.
81. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creuzfeldt-Jakob disease. Lancet 1998;352:703-4.
82. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, et al. Investigation of variant Creuzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-9.
83. Ironside JW, Head MW, Bell JE, McCardle L, Will RG. Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 2000;37:1-9.
84. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creuzfeldt-Jakob disease infectivity in extraneural tissues [letter]. Lancet 2001;358:208-9.
85. Chmel H, Armstrong D. Salmonella oslo: a focal outbreak in a hospital. Am J Med 1976;60:203-8.
86. Tuffnell PG. Salmonella infections transmitted by a gastroscope. Can J Public Health 1976;67:141-2.
87. Dean AG. Transmission of Salmonella typhi by fiberoptic endoscopy [letter]. Lancet 1977;II:134.
88. Beecham III HJ, Cohen ML, Parkin WE. Salmonella typhimurium: transmission by fiberoptic upper gastrointestinal endoscopy. JAMA 1979;241:1013-5.
89. CDC. Salmonella gastroenteritis acquired from gastroduodenoscopy. MMWR Morb Mortal Wkly Rep 1977;26:266.
90. Schliessler KH, Rozendaal B, Taal C, Meawissen SGM. Outbreak of Salmonella agona infection after upper intestinal fibreoptic endoscopy [letter]. Lancet 1980;II:1246.
91. Hawkey PM, Davies AJ, Viant AC, Lush CJ, Mortensen NJ. Contamination of endoscopes by Salmonella species. J Hosp Infect 1981;2:373-6.
92. Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993;118:117-28.
93. O'Connor BH, Bennett JR, Alexander JG, Sutton DR, Leighton I, Mawer SL, et al. Salmonellosis infection transmitted by fibreoptic endoscopes. Lancet 1982;II:864-6.
94. Holmberg SD, Osterholm MT, Senger KA, Cohen ML. Drug-resistant salmonella from animals fed antimicrobials. N Engl J Med 1984;311:617-22.
95. Dwyer DM, Klein G, Istre GR, Robinson MG, Neumann DA, McCoy GA. Salmonella newport infections transmitted by fiberoptic colonoscopy. Gastrointest Endosc 1987;33:84-7.
96. Greene WH, Moody M, Hartley R, Effman E, Aisner J, Young VM, et al. Esophagoscopy as a source of Pseudomonas aeruginosa sepsis in patients with acute leukemia: the need for sterilization of endoscopes. Gastroenterology 1974;67:912-9.
97. Elson CO, Hattori K, Blackstone MO. Polymicrobial sepsis following endoscopic retrograde cholangiopancreatography. Gastroenterology 1975;69:507-10.
98. Low DE, Micflikier AB, Kennedy JK, Stiver G. Infectious complications of endoscopic retrograde cholangiopancreatography: a prospective assessment. Arch Intern Med 1980;140:1076-7.
99. Schousboe M, Carter A, Sheppard PS. Endoscopic retrograde cholangio-pancreatography: related nosocomial infections. N Z Med J 1980;92:275-7.
100. Noy MF, Harrison L, Holmes GKT, Cockel R. The significance of bacterial contamination of fiberoptic endoscopes. J Hosp Infect 1980;1:53-61.
101. Doherty DE, Falko JM, Lefkovitz N, Rogers J, Fromkes J. Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography. Dig Dis Sci 1982;27:169-70.
102. Cryan EMJ, Falkiner FR, Mulvihill TE, Keane CT, Keeling PWN. Pseudomonas aeruginosa cross-infection following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1984;5:371-6.
103. Brayko C, Kozarek R, Sanowski R, Testa A. Bacteremia during esophageal variceal sclerotherapy: its cause and prevention. Gastrointest Endosc 1985;31:10-2.
104. Earnshaw JJ, Clark AW, Thom BT. Outbreak of Pseudomonas aeruginosa following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1985;6:95-7.
105. Davion T, Braillon A, Delamarre J, Delcenserie R, Joly JP, Capron JP. Pseudomonas aeruginosa liver abscesses following endoscopic retrograde cholangiography: report of a case without biliary tract disease. Dig Dis Sci 1987;32:1044-6.
106. Allen JI, Allen MOC, Olson MM, Gerding DN, Shanholtzer CJ, Meier PB, et al. Pseudomonas infection of the biliary system resulting from use of a contaminated endoscope. Gastroenterology 1987;92:759-63.
107. O'Connor HJ, Babb JR, Ayliffe GAJ. Pseudomonas aeruginosa infection during endoscopy [letter]. Gastroenterology 1987;93:1451.
108. Alvarado CJ, Stolz SM, Maki DG. Nosocomial infections from contaminated endoscopes: a flawed automated endoscope washer. An investigation using molecular epidemiology. Am J Med 1991;91(3B):272S-280S.
109. Allen JI. Pseudomonas aeruginosa infection during endoscopy: reply [letter]. Gastroenterology 1987;93:1451.
110. Siegman-Igra Y, Isakov A, Inbar G, Cahaner J. Pseudomonas aeruginosa septicemia following endoscopic retrograde cholangiopancreatography with a contaminated endoscope. Scand J Infect Dis 1987;19:527-30.
111. Siegman-Igra Y, Spinrad S, Rattan J. Septic complications following endoscopic retrograde cholangiopancreatography: the experience in Tel Aviv Medical Center. J Hosp Infect 1988;12:7-12.
112. Classen DC, Jacobson JA, Burke JP, Jacobson JT, Evans RS. Serious Pseudomonas infections associated with endoscopic retrograde cholangiopancreatography. Am J Med 1988;84:590-6.
113. Bass DH, Oliver S, Bornman PC. Pseudomonas septicaemia after endoscopic retrograde cholangiopancreatography: an unresolved problem. S Afr Med J 1990;77:509-11.
114. CDC. Nosocomial infection and pseudoinfection from contaminated endoscopes and bronchoscopes: Wisconsin and Missouri. MMWR Morb Mortal Wkly Rep 1991;40:675-8.
115. Streulens MJ, Rost F, Deplano A, Maas A, Schwam V, Serruys E, et al. Pseudomonas aeruginosa and Entero-bacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med 1993;95:489-98.
116. Pollack M. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE and Dolin R, editors. Principles and practices of infectious diseases. Philadelphia: Churchill Livingstone; 2000. p. 2310-35.
117. Graham DY, Alpert LC, Smith JL, Yoshimura HH. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988;83:974-80.
118. Langenberg W, Rauws EAJ, Oudbier JH, Tytgat GNJ. Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis 1990;161:507-11.
119. Miyaji H, Kohli Y, Azuma T, Ito S, Hirai M, Ito Y, et al. Endoscopic cross-infection with Helicobacter pylori [letter]. Lancet 1995;345:464.
120. Wu MS, Wang JT, Yang JC, Wang HH, Sheu JC, Chen DS, et al. Effective reduction of Helicobacter pylori infection after upper gastrointestinal endoscopy by mechanical washing of the endoscope. Hepatogastroenterology 1996;43:1660-4.
121. Mandelstam P. Sugawa C, Silvis SE, Nebel OT, Rogers BHG. Complications associated with esophagogastroduodenoscopy and with esophageal dilation. Gastrointest Endosc 1976;23:16-9.
122. Godiwala T, Andry M, Agrawal N, Ertan A. Consecutive Serratia marcescens infections following endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1988;34:345-7.
123. Singh S, Singh N, Kochhar R, Mehta SK, Talwar P. Contamination of an endoscope due to Trichosporon beiglli. J Hosp Infect 1989;14:49-53.
124. Lo Passo C, Pernice I, Celeste A, Perdichizzi G, Todaro-Luck F. Transmission of Trichosporon asahii esophagitis by a contaminated endoscope. Mycoses 2001;44:13-21.
125. Cheung RJ, Ortiz D, DiMarino AJ Jr. GI endoscopic reprocessing practices in the United States. Gastrointest Endosc 1999;50:362-8.
126. Jackson FW, Ball MD. Correction of deficiencies in flexible fiberoptic sigmoidoscope cleaning and disinfection technique in family practice and internal medicine offices. Arch Fam Med 1997;6:578-82.
127. Food and Drug Administration. FDA-cleared sterilants and high level disinfectants with general claims for processing reusable medical and dental devices 1/30/02.[cited 2002 Dec 9]. Available from: URL:http://www.fda.gov/cdrh/ode/germlab.html.
128. Food and Drug Administration. MAUDE. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUD/search.CFM.